Lundbeck Pharmaceuticals LLC drugs
7 results
Carnexiv (carbamazepine)
(Carbamazepine)Lundbeck Pharmaceuticals LLC
Usage: CARNEXIV is indicated as replacement therapy for oral carbamazepine when oral administration is not feasible, applicable to adults with partial seizures (complex), generalized tonic-clonic seizures, and mixed seizure patterns. It is not suitable for absence seizures due to potential increased convulsion frequency.
Northera (droxidopa)
(droxidopa)Lundbeck Pharmaceuticals LLC
Usage: NORTHERA is indicated for treating orthostatic dizziness, lightheadedness, or near-blackout sensations in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Long-term effectiveness beyond 2 weeks is not established.
Onfi (clobazam)
(clobazam)Lundbeck Pharmaceuticals LLC
Usage: ONFI (clobazam) is indicated as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome (LGS) in patients aged 2 years and older.
Sabril (vigabatrin)
(vigabatrin)Lundbeck Pharmaceuticals LLC
Usage: SABRIL is indicated for adjunctive therapy in adults and children (2 years and older) with refractory complex partial seizures who have not responded to other treatments. It is also indicated as monotherapy for pediatric patients (1 month to 2 years) with infantile spasms, with careful consideration of potential vision loss risks.
Sabril (vigabatrin)
(vigabatrin)Lundbeck Pharmaceuticals LLC
Usage: SABRIL is indicated as adjunctive therapy for adults and children (2 years and older) with refractory complex partial seizures and as monotherapy for infants (1 month to 2 years) with infantile spasms, where benefits outweigh the risk of vision loss. Not a first-line treatment for complex partial seizures.
Vyepti (eptinezumab-jjmr)
(eptinezumab-jjmr)Lundbeck Pharmaceuticals LLC
Usage: VYEPTI is indicated for the preventive treatment of migraines in adults.
Xenazine (tetrabenazine)
(tetrabenazine)Lundbeck Pharmaceuticals LLC
Usage: XENAZINE is indicated for treating chorea associated with Huntington's disease.